MOBILE VIEW  | 

FIBERGLASS

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Fiberglass is a synthetic mineral fiber of the borosilicate variety which has low alkalinity and is made from heating a mixture of silica, limestone, aluminum hydroxide, soda ash, and borax (calcia-alumina-silica) (ILO, 1998; Lewis, 1996). The fiber-forming substance is glass (Sittig, 1991; Lewis, 1993).

Specific Substances

    1) Glass fiber
    2) Fibrous glass
    3) Fiberglass dust
    4) Borosilicate glass
    5) CAS 659979-17-3
    6) FIBREGLASS
    7) FIBROUS GLASS DUST (ACGIH)
    8) GLASS FIBERS

Available Forms Sources

    A) FORMS
    1) Fiber diameter varies with the type of finished product:
    a) INSULATION: 5 to 15 microns
    b) PLASTIC REINFORCEMENT: 9 to 11 microns
    c) DRAPERY FABRICS: 4 to 6 microns (no longer produced)
    d) STAPLE FIBERS: 6 to 9 microns
    e) HIGH PERFORMANCE INSULATION (aircraft, space vehicles, life preservers): Less than 1 micron
    2) At one textile plant, the majority of textile products produced had the average diameter of 10 to 12 microns (Chiazze et al, 1997).
    B) SOURCES
    1) Fiberglass is a synthetic mineral fiber made from heating a mixture of silica, limestone, aluminum hydroxide, soda ash, and borax (ILO, 1998). After spinning, fibers are generally coated and bonded with phenolformaldehyde resins or starch (ACGIH, 1991).
    C) USES
    1) Fiberglass is found in thermal insulation and in a variety of textile products (ACGIH, 1991; Lewis, 1993).
    2) Textile glass-fiber is used in the following products (Chiazze et al, 1997):
    a) Fiber-reinforced cement, roofing materials, papers, plastic composites (eg; aircraft components, appliance housings, automobile body parts, construction materials, marine products), fiberglass fabrics (cable and wire insulation, filters, high-temperature materials, ignition cable, orthopedic appliances, printed circuit boards, protective apparel, screening, structural materials, tire reinforcement cord, yarns, and thread).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) Fiberglass is a chemically inert substance and produces no known toxic effects upon ingestion. Dermal exposure produces superficial and transient skin irritation.
    0.2.4) HEENT
    A) Transient conjunctivitis may occur from mechanical irritation if fibers come in contact with patient's eyes.
    0.2.6) RESPIRATORY
    A) Bronchitis has occurred during removal of non-intact fiberglass bats, although a direct causal relationship is questionable.
    B) Chronic inhalational exposure has been associated with an excess of bronchitis, but only rarely with pulmonary fibrosis and no association with lung cancer has been demonstrated in humans.
    C) Immediate allergic responses, with wheezing, dyspnea, or anaphylaxis may occur rarely following inhalational exposure.
    0.2.14) DERMATOLOGIC
    A) Initial skin contact with fibers greater than 5.3 microns in diameter may produce an irritant dermatitis in many individuals. Tolerance may develop with chronic exposure. Dermatitis caused by secondary exposure through contaminated clothing or fabrics has occurred.
    0.2.20) REPRODUCTIVE
    A) At the time of this review, no data were available to assess the potential effects of exposure to this agent during pregnancy or lactation.
    0.2.21) CARCINOGENICITY
    A) There is no consistent evidence that fiberglass causes cancer in humans.

Laboratory Monitoring

    A) Chest x-rays may be helpful in evaluating patients with respiratory signs or symptoms following acute and periodically after chronic exposures to fiberglass.

Treatment Overview

    0.4.3) INHALATION EXPOSURE
    A) INHALATION: Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with an inhaled beta2-adrenergic agonist. Consider systemic corticosteroids in patients with significant bronchospasm.
    0.4.4) EYE EXPOSURE
    A) DECONTAMINATION: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, the patient should be seen in a healthcare facility.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) DECONTAMINATION: Remove contaminated clothing and jewelry and place them in plastic bags. Wash exposed areas with soap and water for 10 to 15 minutes with gentle sponging to avoid skin breakdown. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    2) Wash exposed clothing separately in a tub or basin (NOT in a washing machine), as this may cross-contaminate clothes. Wear rubber gloves and rinse tub or basin thoroughly after using.
    3) TREATMENT - Antihistamines may be helpful to control pruritus following dermatologic exposures, and topical steroids may help with dermatitis. Dermatitis may also respond to topical steroids.
    4) Treat secondary skin or respiratory infections with appropriate antibiotics.

Summary Of Exposure

    A) Fiberglass is a chemically inert substance and produces no known toxic effects upon ingestion. Dermal exposure produces superficial and transient skin irritation.

Heent

    3.4.1) SUMMARY
    A) Transient conjunctivitis may occur from mechanical irritation if fibers come in contact with patient's eyes.
    3.4.3) EYES
    A) CONJUNCTIVITIS - Transient conjunctivitis and keratitis have been described following ocular exposure. Irritant effects are mechanical in origin and may be complicated by corneal abrasions(Longley & Jones, 1966; Grant, 1993; Lewis, 1996).
    3.4.5) NOSE
    A) EPISTAXIS may occur following inhalational exposure.
    B) RHINITIS - Rhinorrhea or nasal congestion may occur (Petersen & Sebroe, 1991).
    3.4.6) THROAT
    A) CORYZA - Nasopharyngitis with symptoms of sore throat and coryza may occur following inhalational exposure.

Respiratory

    3.6.1) SUMMARY
    A) Bronchitis has occurred during removal of non-intact fiberglass bats, although a direct causal relationship is questionable.
    B) Chronic inhalational exposure has been associated with an excess of bronchitis, but only rarely with pulmonary fibrosis and no association with lung cancer has been demonstrated in humans.
    C) Immediate allergic responses, with wheezing, dyspnea, or anaphylaxis may occur rarely following inhalational exposure.
    3.6.2) CLINICAL EFFECTS
    A) PNEUMONITIS
    1) CASE - Bronchitis, bronchiolitis, and pneumonitis have occurred during removal of partially deteriorated fiberglass bats (Murphy, 1961), although a direct causal relationship is questionable.
    B) FIBROSIS OF LUNG
    1) CHRONIC TOXICITY
    a) Although pulmonary fibrosis and bronchiectasis have been described in patients with chronic inhalational exposures to fiberglass fibers, this is not common and other etiologies may have been involved (Takahashi et al, 1996; ACGIH, 1991). In long-term studies of fiberglass workers, no fibrosis or inflammatory changes were present on chest x-ray (Wright, 1968). Other studies have corroborated this lack of association (Gross, 1986).
    2) PULMONARY ABNORMALITIES -
    a) CHRONIC TOXICITY
    1) CASE SERIES - A study of 500 workers with occupational exposure to fiberglass concluded that 13 percent had pulmonary opacities or pleural abnormalities that may have been secondary to fiberglass exposure (Kilburn et al, 1992). However, these workers were also exposed to asbestos, making causative interpretation difficult.
    3) CHRONIC BRONCHITIS -
    a) CHRONIC TOXICITY
    1) In a questionnaire study of 333 retired sheet metal workers with 20 or more years in this trade, those with heavy fiberglass exposure had a more than 2 times increased risk of developing chronic bronchitis, although mixed exposure to asbestos and tobacco smoking were confounders (Hunting and Welch, 1993). Studies of workers in fiberglass manufacturing have generally found only tobacco smoking to be related to the development of chronic non-malignant respiratory disease (Chiazze et al, 1992; Chiazze et al, 1993).
    4) HEMORRHAGE -
    a) CHRONIC TOXICITY
    1) Rupture of small arteries in the upper respiratory tract, with resultant hemoptysis, has been described following inhalational exposure to fiberglass.
    C) ACUTE ALLERGIC REACTION
    1) An immediate allergic response with coughing, wheezing, and dyspnea occurs rarely with inhalational exposures.
    3.6.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) SARCOMA
    a) Inhalation studies in animals do not indicate fiberglass as a cause of fibrosis; however, studies where small fibers were implanted into the chest showed development of pleural sarcomas (Stanton et al, 1977).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) RENAL FAILURE SYNDROME
    1) END STAGE RENAL DISEASE - In one review article discussing various cohort studies, it was suggested that inhalational exposure to fiberglass or silica may increase the long-term risk of renal disease including renal failure (Goldsmith & Goldsmith, 1993), although this has not been confirmed.

Dermatologic

    3.14.1) SUMMARY
    A) Initial skin contact with fibers greater than 5.3 microns in diameter may produce an irritant dermatitis in many individuals. Tolerance may develop with chronic exposure. Dermatitis caused by secondary exposure through contaminated clothing or fabrics has occurred.
    3.14.2) CLINICAL EFFECTS
    A) DERMATITIS
    1) INCIDENCE
    a) Irritant dermatitis occurs in most people following initial dermal exposure to fibers thicker than 5.3 microns (ACGIH, 1991). Fibers less than 4.6 microns in diameter are probably not irritating to the skin (ACGIH, 1991). Fiberglass dermatitis is one of the most prevalent occupational dermatoses documented (Alam, 1998; Lewis, 1996; Raffle et al, 1994; Mathias, 1994). Fair-skinned, blue-eyed individuals appear to be more sensitive to the dermatitis (Fisher, 1982).
    b) Dermatitis has resulted from washing exposed clothing or fabrics containing fiberglass with other household clothing and thus cross-contaminating these other clothes (Possick et al, 1970). Working with printed circuit boards, handling fiberglass ceiling panels, and handling fiberglass mats have all resulted in fiberglass dermatitis (Koh et al, 1992; Wang et al, 1993; Chang et al, 1996).
    2) SYMPTOMS - Burning, intense pruritus and erythema results from actual mechanical penetration of fiberglass glass spicules into the epidermis. This induces the release of histamine resulting in a cascade of clinical effects (Raffle et al, 1994; Mathias, 1994). The initial lesion may begin as a papule or papulo-vesicle. Dermatitis is often then aggravated by scratching, which may lead to bacterial superinfection. Linear erosions, petechiae, and purpura may develop. Lichenification is common in chronic exposures or symptoms.
    3) RESPONSE TO IMBEDDED PARTICLES - Penetration of large particles into nails or skin may result in paronychia or "fiberglass warts" (Fisher, 1989).
    4) RISK FACTORS - With chronic exposure, tolerance or "hardening" develops in most individuals (Fisher, 1982), and usually occurs over a few week period (Raffle et al, 1994).
    5) The finished fiberglass products are usually cured with coating agents, and should not cause dermatitis symptoms.
    6) The major allergen to continuous filament fibrous glass workers is the epoxy resin (Conde-Salazar et al, 1985; Holness & Nethercott, 1989). Such resins however, are not used in fiberglass insulating materials.
    7) Some cases of dermatitis caused by fiberglass products may be due to the binders or coating materials used in the manufacturing process, rather than the fiberglass fibers themselves. Phenolformaldehyde resins are used most commonly, but starch, mineral oil, polyvinyl chloride, silicones, polyester and epoxy resins, urea, melamine-formaldehyde resins, polyvinyl acetate, dyes, ammonium hydroxide, and silanes may also be used.
    B) ERYTHEMA MULTIFORME
    1) CASE REPORT - Erythema multiforme has been reported in a 23-year-old woman who had handled fiberglass with bare hands (Camarasa & Moreno, 1984).
    C) GRANULOMA
    1) CASE - A single case of a fiberglass worker who developed a granulomatous lesion on his penis has been reported (Hinnen et al, 1997).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) SYNOVITIS
    1) CASE REPORT - Chronic synovitis with effusion was reported in a 25-year-old man who manufactured surfboards using fiberglass. Examination of the synovial fluid revealed many glass fibers (long glass filaments) (Cleland et al, 1984).

Immunologic

    3.19.2) CLINICAL EFFECTS
    A) ANAPHYLACTOID REACTION
    1) Anaphylaxis has been reported in fiberglass product exposures (Zanjanian & Sahu, 1981), but may have been caused by the coating material rather than the fiberglass itself.

Reproductive

    3.20.1) SUMMARY
    A) At the time of this review, no data were available to assess the potential effects of exposure to this agent during pregnancy or lactation.
    3.20.3) EFFECTS IN PREGNANCY
    A) LACK OF INFORMATION
    1) At the time of this review, no data were available to assess the potential effects of exposure to this agent during pregnancy or lactation.

Carcinogenicity

    3.21.1) IARC CATEGORY
    A) IARC Carcinogenicity Ratings for CAS65997-17-3 (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004):
    1) Not Listed
    3.21.2) SUMMARY/HUMAN
    A) There is no consistent evidence that fiberglass causes cancer in humans.
    3.21.3) HUMAN STUDIES
    A) SUMMARY
    1) Fibrous glass is NOT currently labeled as a possible human carcinogen by the ACGIH (ACGIH, 1991) 1998) or NIOSH (US DHHS, 1994). No entries were found in the OSHA CFR 29.1910 regulations (OSHA, 1995) or the IRIS system (1998) for fiberglass or glass wool. No human carcinogenic data from fiberglass exposure (as fibrous glass) was reported in the RTECS(R) system (RTECS, 1998).
    2) Respirable sized glass wool is labeled by the National Toxicology Program as a substance which may reasonably be anticipated to be a carcinogen, based on experimental animal studies in which intratracheal instillation or intraperitoneal injection in rats or hamsters resulted in cancer and tumors of the respiratory tract or other organs (US DHHS, 1994a).
    3) Several papers are available which review and re-analyze data from epidemiological studies concerning fiberglass (Lee et al, 1995; Chiazze et al, 1995). The consensus reached in these publications is that in the absence of cigarette smoking, there appears to be no excessive risk of cancer due to fiberglass (Alam, 1998).
    4) Epidemiological evidence does not support the presence of carcinogenic effects due to fiberglass on most humans (Enterline & Henderson, 1975; Bayliss et al, 1976; ILO, 1998; Alam, 1998). Two studies have suggested an association between fiberglass exposure for 15 years or more and laryngeal cancer, however these were inconclusive (Bertazzi et al, 1986; Moulin et al, 1986).
    a) A number of epidemiologic studies have not demonstrated that occupational fiberglass exposure results in an increased risk of developing lung cancer or non-malignant respiratory diseases; tobacco smoking however, was implicated in the development of these diseases in many studies (Marsh et al, 1990; Shannon et al, 1990; Wong et al, 1991; Chiazze et al, 1992) Chaizze et al, 1993; (Lee et al, 1995; Chiazze et al, 1997; Watkins et al, 1997).
    5) The IARC has classified various man-made mineral fibers as follows (IARC, 1988):
    Glass Wool:Group 2B (Possibly carcinogenic to humans)
    Glass Filaments:Group 3 (Not classifiable as to their carcinogenicity to humans)
    Rock Wool:Group 2B (Possibly carcinogenic to humans)
    Slag Wool:Group 2B (Possibly carcinogenic to humans)
    Ceramic Fibers:Group 2B (Possible carcinogenic to humans)

    B) CARCINOMA
    1) One review of all published studies on glass wool man-made mineral fiber has concluded that it is carcinogenic and may be more potent than asbestos on a fiber-by-fiber basis (Infante et al, 1994). Fibrous glass (continuous glass filaments) in general has not been shown to be a human carcinogen (ACGIH, 1991; IARC, 1987; ILO, 1998; Alam, 1998).
    2) Special purpose refractory ceramic fibers are not classified with fiberglass in this review. The respirable size refractory ceramic fibers are currently under investigation for potential adverse health effects (Glass et al, 1995).
    3.21.4) ANIMAL STUDIES
    A) CARCINOMA
    1) Respirable glass wool fibers of a size that may be inhaled (<3.2 to <7 microns in length by <0.18 to 1 microns in diameter) produced adenocarcinomas, squamous cell carcinomas, lung carcinoma, bronchoalveolar tumors, mesotheliomas, and sarcomas in rats and hamsters after intratracheal instillation. Mesotheliomas and sarcomas developed in rats following intraperitoneal injection. The results of animal studies involving inhalation of airborne fibers have been negative or inadequate (US DHHS, 1994).
    B) SARCOMA
    1) A dose-related carcinogenic response has been found in rats when fibrous glass (fibers less than 0.5 micron in diameter) was injected or implanted into the chest. Sarcomas and rare mesotheliomas developed (Stanton et al, 1977; Wagner et al, 1973; Pott & Friedrichs, 1972).
    C) OTHER
    1) RTECS CLASSIFICATIONS - In rats, mice, rabbits, and hamsters exposed to fibers by inhalation, implantation, and by intrapleural, intraperitoneal, or intratracheal routes, fiberglass was carcinogenic, neoplastic, or an equivocal tumorigenic agent by RTECS criteria (RTECS, 1998).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Chest x-rays may be helpful in evaluating patients with respiratory signs or symptoms following acute and periodically after chronic exposures to fiberglass.
    4.1.2) SERUM/BLOOD
    A) No specific lab work (CBC, electrolytes, urinalysis) is needed unless otherwise clinically indicated.
    4.1.4) OTHER
    A) OTHER
    1) DERMAL
    a) Fiberglass dermatitis may be confirmed by demonstrating glass spicules on KOH preparation slides taken from the affected area.
    b) Another technique consists of placing a drop of cyanoacrylate glue on the skin, pressing a clean glass slide on the drop for 30 seconds, removing the slide, and looking for the fibers under polarized light. Polyester tape may be used instead of a glass slide (Lachapelle, 1986; Raffle et al, 1994).

Radiographic Studies

    A) CHEST RADIOGRAPH
    1) Chest x-rays may be helpful in evaluating patients with respiratory signs or symptoms following acute exposure, or in monitoring patients with chronic exposures.

Methods

    A) OTHER
    1) AIRBORNE FIBERS - May be collected by drawing a known volume of air through a cassette containing a mixed cellulose ester filter. Fibers may be counted using NIOSH 7400 procedures for filter preparation and fiber identification. Fibers less than 3 micrometers in diameter are considered respirable (Jacob et al, 1993).

Life Support

    A) Support respiratory and cardiovascular function.

Monitoring

    A) Chest x-rays may be helpful in evaluating patients with respiratory signs or symptoms following acute and periodically after chronic exposures to fiberglass.

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) Move patient from the toxic environment to fresh air. Monitor for respiratory distress. If cough or difficulty in breathing develops, evaluate for hypoxia, respiratory tract irritation, bronchitis, or pneumonitis.
    B) OBSERVATION: Carefully observe patients with inhalation exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.
    C) INITIAL TREATMENT: Administer 100% humidified supplemental oxygen, perform endotracheal intubation and provide assisted ventilation as required. Administer inhaled beta-2 adrenergic agonists, if bronchospasm develops. Consider systemic corticosteroids in patients with significant bronchospasm (National Heart,Lung,and Blood Institute, 2007). Exposed skin and eyes should be flushed with copious amounts of water.
    6.7.2) TREATMENT
    A) MONITORING OF PATIENT
    1) Chest x-rays may be helpful in evaluating patients with respiratory signs or symptoms following acute and periodically after chronic exposures to fiberglass.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DERMAL DECONTAMINATION
    1) DECONTAMINATION: Remove contaminated clothing and wash exposed area thoroughly with soap and water for 10 to 15 minutes. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    6.9.2) TREATMENT
    A) SUPPORT
    1) Antihistamines may be helpful to control pruritus following dermatologic exposures, and topical steroids may help with dermatitis. Dermatitis may also respond to topical steroids.
    B) ANTIBIOTIC
    1) Treat secondary skin or respiratory infections with appropriate antibiotics.
    C) PROTECTING FROM CROSS-CONTAMINATION
    1) Wash exposed clothing separately in a tub or basin (NOT in a washing machine, as this may cross-contaminate clothes). Wear rubber gloves and rinse tub or basin thoroughly after use.
    D) WOUND CARE
    1) Embedded fiberglass particles in fingertips have been removed by applying a keratolytic agent, such as 5% salicylic acid in petrolatum (Fisher, 1989).
    E) IRRITATION SYMPTOM
    1) Emollient cream or ointment barrier products were of limited benefit in preventing irritation from fibers in glass fiber workers (Bendsoe et al, 1987).

Workplace Standards

    A) ACGIH TLV Values for CAS65997-17-3 (American Conference of Governmental Industrial Hygienists, 2010):
    1) Not Listed

    B) NIOSH REL and IDLH Values for CAS65997-17-3 (National Institute for Occupational Safety and Health, 2007):
    1) Not Listed

    C) Carcinogenicity Ratings for CAS65997-17-3 :
    1) ACGIH (American Conference of Governmental Industrial Hygienists, 2010): Not Listed
    2) EPA (U.S. Environmental Protection Agency, 2011): Not Listed
    3) IARC (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004): Not Listed
    4) NIOSH (National Institute for Occupational Safety and Health, 2007): Not Listed
    5) MAK (DFG, 2002): Not Listed
    6) NTP (U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project ): Not Listed

    D) OSHA PEL Values for CAS65997-17-3 (U.S. Occupational Safety, and Health Administration (OSHA), 2010):
    1) Not Listed

General Bibliography

    1) 40 CFR 372.28: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Lower thresholds for chemicals of special concern. National Archives and Records Administration (NARA) and the Government Printing Office (GPO). Washington, DC. Final rules current as of Apr 3, 2006.
    2) 40 CFR 372.65: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Chemicals and Chemical Categories to which this part applies. National Archives and Records Association (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Apr 3, 2006.
    3) 49 CFR 172.101 - App. B: Department of Transportation - Table of Hazardous Materials, Appendix B: List of Marine Pollutants. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 29, 2005.
    4) 62 FR 58840: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 1997.
    5) 65 FR 14186: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    6) 65 FR 39264: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    7) 65 FR 77866: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    8) 66 FR 21940: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2001.
    9) 67 FR 7164: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2002.
    10) 68 FR 42710: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2003.
    11) 69 FR 54144: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2004.
    12) ACGIH: Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th ed, Am Conference of Govt Ind Hyg, Inc, Cincinnati, OH, 1991.
    13) AIHA: 2006 Emergency Response Planning Guidelines and Workplace Environmental Exposure Level Guides Handbook, American Industrial Hygiene Association, Fairfax, VA, 2006.
    14) Alam W: Manufactured Mineral Fibers, in: Harbison RM (Ed), Hamilton & Hardy's Industrial Toxicology, 5th ed, Mosby, St Louis, MO, 1998, pp 571-572.
    15) American Conference of Governmental Industrial Hygienists : ACGIH 2010 Threshold Limit Values (TLVs(R)) for Chemical Substances and Physical Agents and Biological Exposure Indices (BEIs(R)), American Conference of Governmental Industrial Hygienists, Cincinnati, OH, 2010.
    16) Bayliss DL, Dement J, & Wagoner JK: Occupational Exposure to Fibrous Glass: A Symposium, US Dept Health, Education & Welfare, Washington, DC, 1976.
    17) Bendsoe N, Bjornberg A, & Lowhagen BB: Glass fibre irritation and protective creams. Contact Dermatitis 1987; 17:69-72.
    18) Bertazzi PA, Zocchetti C, & Riboldi L: Cancer mortality of an Italian cohort of workers in man-made glass-fiber production. Scand J Work Environ Health 1986; 12(Suppl 1):65-71.
    19) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    20) Camarasa JG & Moreno A: Fiberglass dermatitis. Contact Derm 1984; 10:43.
    21) Chang CH, Wang CM, & Ho CK: Fiberglass dermatitis: A case report. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1996; 12:491-494.
    22) Chiazze L, Watkins DK, & Fryar C: A case-control study of malignant and non-malignant respiratory disease among employees of a fiberglass manufacturing facility. Br J Ind Med 1992; 49:326-331.
    23) Chiazze L, Watkins DK, & Fryar C: A case-control study of malignant and non-malignant respiratory disease among employees of a fiberglass manufacturing facility. II. Exposure assessment. Br J Ind Med 1993; 50:717-725.
    24) Chiazze L, Watkins DK, & Fryar C: Adjustment for the confounding effect of cigarette smoking in an historical cohort mortality study of workers in a fiberglass manufacturing facility. J Occup Environ Med 1995; 37:744-748.
    25) Chiazze L, Watkins DK, & Fryar C: Historical cohort mortality study of a continuous filament fiberglass manufacturing plant. I. White men. J Occup Environ Med 1997; 39:432-441.
    26) Cleland LG, Vernon-Roberts B, & Smith K: Fibre glass induced synovitis. Ann Rheum Dis 1984; 43:530-534.
    27) Conde-Salazar L, Guimaraens D, & Romero LV: Occupational dermatitis from glass fiber. Contact Dermatitis 1985; 13:195-196.
    28) DFG: List of MAK and BAT Values 2002, Report No. 38, Deutsche Forschungsgemeinschaft, Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Wiley-VCH, Weinheim, Federal Republic of Germany, 2002.
    29) EPA: Search results for Toxic Substances Control Act (TSCA) Inventory Chemicals. US Environmental Protection Agency, Substance Registry System, U.S. EPA's Office of Pollution Prevention and Toxics. Washington, DC. 2005. Available from URL: http://www.epa.gov/srs/.
    30) Enterline PE & Henderson V: The health of retired fibrous glass workers. Arch Environ Health 1975; 30:113-116.
    31) Fisher AA: Fiberglass vs mineral wool (Rockwool) dermatitis. Cutis 1982; 29:412-513.
    32) Fisher AA: Rust remover rash (Letter). J Am Acad Dermatol 1989; 20:142.
    33) Glass LR, Brown RC, & Hoskins JA: Health effects of refractory ceramic fibres: scientific issues and policy considerations. Occup Environ Med 1995; 52:433-440.
    34) Goldsmith JR & Goldsmith DF: Fiberglass or silica exposure and increased nephritis or ESRD (end-stage renal disease). Am J Ind Med 1993; 23:873-881.
    35) Grant WM: Toxicology of the eye, 4th ed, Charles C Thomas, Springfield, IL, 1993, pp 687.
    36) Gross P: Man-made vitreous fibers: an overview of studies on their biological effects. Am Ind Hyg Assoc J 1986; 47:717-723.
    37) Hinnen U, Elsner P, & Barraud M: Foreign body granuloma of the penis caused by occupational glass fibre exposure. Genitourin Med 1997; 73:577-578.
    38) Holness DL & Nethercott JR: Occupational contact dermatitis due to epoxy resin in a fiberglass binder. J Occup Med 1989; 31:87-89.
    39) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide), 97, International Agency for Research on Cancer, Lyon, France, 2008.
    40) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol, 88, International Agency for Research on Cancer, Lyon, France, 2006.
    41) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Household Use of Solid Fuels and High-temperature Frying, 95, International Agency for Research on Cancer, Lyon, France, 2010a.
    42) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, 89, International Agency for Research on Cancer, Lyon, France, 2007.
    43) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures, 92, International Agency for Research on Cancer, Lyon, France, 2010.
    44) IARC: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans -- Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, Supplement 7, International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland, 1987.
    45) IARC: List of all agents, mixtures and exposures evaluated to date - IARC Monographs: Overall Evaluations of Carcinogenicity to Humans, Volumes 1-88, 1972-PRESENT. World Health Organization, International Agency for Research on Cancer. Lyon, FranceAvailable from URL: http://monographs.iarc.fr/monoeval/crthall.html. As accessed Oct 07, 2004.
    46) ILO: Encyclopaedia of Occupational Health and Safety, 4th ed, Vol 1-4, Stellman JM (Ed), International Labour Organization, Geneva, Switzerland, 1998.
    47) Infante PF, Schuman LD, & Dement J: Fibrous glass and cancer. Am J Ind Med 1994; 26:559-584.
    48) International Agency for Research on Cancer (IARC): IARC monographs on the evaluation of carcinogenic risks to humans: list of classifications, volumes 1-116. International Agency for Research on Cancer (IARC). Lyon, France. 2016. Available from URL: http://monographs.iarc.fr/ENG/Classification/latest_classif.php. As accessed 2016-08-24.
    49) International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. World Health Organization. Geneva, Switzerland. 2015. Available from URL: http://monographs.iarc.fr/ENG/Classification/. As accessed 2015-08-06.
    50) Jacob TR, Hadley JG, & Bender JR: Airborne glass fiber concentrations during manufacturing operations involving glass wool insulation. Am Ind Hyg Assoc J 1993; 54:320-326.
    51) Kilburn KH, Powers D, & Warshaw RH: Pulmonary effects of exposure to fine fiberglass: irregular opacities and small airways obstruction. Br J Ind Med 1992; 49:714-720.
    52) Koh D, Aw TC, & Foulds IS: Fiberglass dermatitis from printed circuit boards. Am J Ind Med 1992; 21:193-198.
    53) Lachapelle JM: Industrial airborne irritant or allergic contact dermatitis. Contact Derm 1986; 14:137-145.
    54) Lee IM, Hennekens CH, & Trichopoulos D: Man-made vitreous fibers and risk of respiratory system cancer: A review of the epidemiologic evidence. J Occup Environ Med 1995; 37:725-738.
    55) Lewis RJ: Hawley's Condensed Chemical Dictionary, 12th ed, Van Nostrand Reinhold Company, New York, NY, 1993, pp 498-538.
    56) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 9th ed, Van Nostrand Reinhold Company, New York, NY, 1996, pp 1646-1647.
    57) Longley EO & Jones RC: Fiberglass conjunctivitis and keratitis. Arch Environ Health 1966; 13:790-793.
    58) Marsh GM, Enterline PE, & Stone RA: Mortality among a cohort of US man-made mineral fiber workers: 1985 follow-up. J Occup Med 1990; 32:594-604.
    59) Mathias GGT: Occupational Dermatoses, in: Zenz C (Ed), Occupational Medicine, 3rd ed, Mosby - Year Book, Inc, St Louis, MO, 1994, pp 93-104.
    60) Moulin JJ, Mur JM, & Wild P: Oral cavity and laryngeal cancers among man-made mineral fiber productions workers. Scand J Work Environ Health 1986; 12:27-3.
    61) Murphy GB: Fiber glass pneumoconiosis. Arch Environ Health 1961; 3:704-710.
    62) NFPA: Fire Protection Guide to Hazardous Materials, 13th ed., National Fire Protection Association, Quincy, MA, 2002.
    63) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 1, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2001.
    64) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 2, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2002.
    65) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 3, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2003.
    66) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 4, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2004.
    67) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
    68) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,3-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    69) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,4-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    70) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Butylene Oxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648083cdbb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    71) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Dibromoethane (Proposed). United States Environmental Protection Agency. Washington, DC. 2007g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802796db&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
    72) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,3,5-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    73) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 2-Ethylhexyl Chloroformate (Proposed). United States Environmental Protection Agency. Washington, DC. 2007b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037904e&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    74) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Acrylonitrile (Proposed). United States Environmental Protection Agency. Washington, DC. 2007c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648028e6a3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    75) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Adamsite (Proposed). United States Environmental Protection Agency. Washington, DC. 2007h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    76) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Agent BZ (3-quinuclidinyl benzilate) (Proposed). United States Environmental Protection Agency. Washington, DC. 2007f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ad507&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
    77) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Allyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039d9ee&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    78) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    79) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Arsenic Trioxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480220305&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    80) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Automotive Gasoline Unleaded (Proposed). United States Environmental Protection Agency. Washington, DC. 2009a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cc17&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    81) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Biphenyl (Proposed). United States Environmental Protection Agency. Washington, DC. 2005j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1b7&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    82) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bis-Chloromethyl Ether (BCME) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648022db11&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    83) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Boron Tribromide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae1d3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    84) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromine Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2007d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039732a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    85) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromoacetone (Proposed). United States Environmental Protection Agency. Washington, DC. 2008e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187bf&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    86) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Calcium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    87) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae328&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    88) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Sulfide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037ff26&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    89) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Chlorobenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803a52bb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    90) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Cyanogen (Proposed). United States Environmental Protection Agency. Washington, DC. 2008f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187fe&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    91) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Dimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbf3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    92) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Diphenylchloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    93) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091884e&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    94) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Phosphorodichloridate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480920347&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    95) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809203e7&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    96) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    97) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Germane (Proposed). United States Environmental Protection Agency. Washington, DC. 2008j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963906&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    98) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Hexafluoropropylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1f5&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    99) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ketene (Proposed). United States Environmental Protection Agency. Washington, DC. 2007. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ee7c&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    100) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    101) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    102) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Malathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2009k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809639df&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    103) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Mercury Vapor (Proposed). United States Environmental Protection Agency. Washington, DC. 2009b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a087&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    104) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Isothiocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a03&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    105) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a57&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    106) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl tertiary-butyl ether (Proposed). United States Environmental Protection Agency. Washington, DC. 2007a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802a4985&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    107) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methylchlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5f4&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    108) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    109) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c646&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    110) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN1 CAS Reg. No. 538-07-8) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    111) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN2 CAS Reg. No. 51-75-2) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    112) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN3 CAS Reg. No. 555-77-1) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    113) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Tetroxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091855b&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    114) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Trifluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e0c&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    115) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008o. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e32&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    116) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perchloryl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e268&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    117) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perfluoroisobutylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2009d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26a&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    118) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008p. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dd58&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    119) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2006d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020cc0c&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    120) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    121) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phorate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008q. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dcc8&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    122) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene (Draft-Revised). United States Environmental Protection Agency. Washington, DC. 2009e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a08a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    123) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene Oxime (Proposed). United States Environmental Protection Agency. Washington, DC. 2009f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26d&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    124) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    125) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    126) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Propargyl Alcohol (Proposed). United States Environmental Protection Agency. Washington, DC. 2006e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec91&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    127) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Selenium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec55&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    128) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Silane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d523&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    129) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    130) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    131) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Strontium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    132) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sulfuryl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec7a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    133) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tear Gas (Proposed). United States Environmental Protection Agency. Washington, DC. 2008s. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e551&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    134) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tellurium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e2a1&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    135) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tert-Octyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2008r. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5c7&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    136) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tetramethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-17.
    137) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    138) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7d608&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    139) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethylacetyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008t. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5cc&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    140) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Zinc Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    141) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for n-Butyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064808f9591&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    142) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    143) National Institute for Occupational Safety and Health: NIOSH Pocket Guide to Chemical Hazards, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Cincinnati, OH, 2007.
    144) National Research Council : Acute exposure guideline levels for selected airborne chemicals, 5, National Academies Press, Washington, DC, 2007.
    145) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 6, National Academies Press, Washington, DC, 2008.
    146) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 7, National Academies Press, Washington, DC, 2009.
    147) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 8, National Academies Press, Washington, DC, 2010.
    148) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
    149) Possick PA, Gellin GA, & Key MM: Fibrous glass dermatitis. Am Ind Hyg Assoc J 1970; 81:12-15.
    150) Pott F & Friedrichs KH: Naturwissenschaften 1972; 59:318.
    151) Raffle PAB, Adams PH, & Baxter PJ: Hunter's Diseases of Occupations, Little, Brown & Co, Boston, MA, 1994, pp 704-705.
    152) Shannon HS, Jamieson E, & Julian JA: Mortality of glass filament (textile) workers. Br J Ind Med 1990; 47:533-536.
    153) Sittig M: Handbook of Toxic and Hazardous Chemicals and Carcinogens, Vol 1-2, 3rd ed, Noyes Publications, Park Ridge, NJ, 1991, pp 814-816.
    154) Stanton MF, Layard M, & Tegelis A: Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst 1977; 58:587-597.
    155) Takahashi T, Munakata M, & Takekawa H: Pulmonary fibrosis in a carpenter with long-lasting exposure to fiberglass. Am J Ind Med 1996; 30:596-600.
    156) U.S. Department of Energy, Office of Emergency Management: Protective Action Criteria (PAC) with AEGLs, ERPGs, & TEELs: Rev. 26 for chemicals of concern. U.S. Department of Energy, Office of Emergency Management. Washington, DC. 2010. Available from URL: http://www.hss.doe.gov/HealthSafety/WSHP/Chem_Safety/teel.html. As accessed 2011-06-27.
    157) U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project : 11th Report on Carcinogens. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Washington, DC. 2005. Available from URL: http://ntp.niehs.nih.gov/INDEXA5E1.HTM?objectid=32BA9724-F1F6-975E-7FCE50709CB4C932. As accessed 2011-06-27.
    158) U.S. Environmental Protection Agency: Discarded commercial chemical products, off-specification species, container residues, and spill residues thereof. Environmental Protection Agency's (EPA) Resource Conservation and Recovery Act (RCRA); List of hazardous substances and reportable quantities 2010b; 40CFR(261.33, e-f):77-.
    159) U.S. Environmental Protection Agency: Integrated Risk Information System (IRIS). U.S. Environmental Protection Agency. Washington, DC. 2011. Available from URL: http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showSubstanceList&list_type=date. As accessed 2011-06-21.
    160) U.S. Environmental Protection Agency: List of Radionuclides. U.S. Environmental Protection Agency. Washington, DC. 2010a. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
    161) U.S. Environmental Protection Agency: List of hazardous substances and reportable quantities. U.S. Environmental Protection Agency. Washington, DC. 2010. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
    162) U.S. Environmental Protection Agency: The list of extremely hazardous substances and their threshold planning quantities (CAS Number Order). U.S. Environmental Protection Agency. Washington, DC. 2010c. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-part355.pdf. As accessed 2011-06-17.
    163) U.S. Occupational Safety and Health Administration: Part 1910 - Occupational safety and health standards (continued) Occupational Safety, and Health Administration's (OSHA) list of highly hazardous chemicals, toxics and reactives. Subpart Z - toxic and hazardous substances. CFR 2010 2010; Vol6(SEC1910):7-.
    164) U.S. Occupational Safety, and Health Administration (OSHA): Process safety management of highly hazardous chemicals. 29 CFR 2010 2010; 29(1910.119):348-.
    165) US DHHS: NIOSH Pocket Guide to Chemical Hazards, National Institute for Occupational Safety and Health, US DHHS, Cincinnati, OH, 1994.
    166) US DHHS: Seventh Annual Report on Carcinogens - 1994, National Toxicology Program, US DHHS, Washington, DC, 1994a.
    167) United States Environmental Protection Agency Office of Pollution Prevention and Toxics: Acute Exposure Guideline Levels (AEGLs) for Vinyl Acetate (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6af&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    168) Wagner JC, Berry G, & Timbrell V: Br J Cancer 1973; 28:173.
    169) Wang BJ, Lee JY, & Wang RC: Fiberglass dermatitis: Report of two cases. J Formos Med Assoc 1993; 92:755-758.
    170) Watkins DK, Chiazze L, & Fryar C: Historical cohort mortality study of a continuous filament fiberglass manufaturing plant. II. Women and minorities. J Occup Environ Med 1997; 39:548-555.
    171) Wong O, Foliart D, & Trent LS: A case-control study of lung cancer in a cohort of workers potentially exposed to slag wool fibers. Br J Ind Med 1991; 48:818-824.
    172) Wright GW: Airborne fibrous glass particles. Arch Environ Health 1968; 16:175-181.